Adverse Event Management in HR+/HER2– Advanced Breast Cancer: PI3K/AKT/PTEN Pathway - Episode 5
Adverse Event Management: Strategies for Reducing Diarrhea Risk in Capivasertib Therapy
Panelists discuss the strategies they employ to manage adverse events in patients starting capivasertib, including minimizing the risk of diarrhea through dietary considerations and patient education, as well as approaches for monitoring and managing rash associated with the treatment and providing education about it.
Video content above is prompted by the following:
1. All faculty: When it comes to adverse event management, what steps do you take to minimize the risk of diarrhea in patients starting capivasertib?
- Please comment on the study that evaluated the effect of food and acid-reducing agents on capivasertib. C. Miller BJCP 2023
- What education do you provide the patient/caregiver about when to call your practice?
2. All faculty: What strategies do you use to monitor and manage rash and provide education about it in patients on capivasertib?
Related Content:
